711 followers
Vascular disruptive agent OXi4503 and anti-angiogenic agent Sunitinib combination treatment prolong survival of… https://t.co/8nuWHnZfPq
Vascular disruptive agent OXi4503 and anti-angiogenic agent Sunitinib combination treatment prolong survival of… https://t.co/8nuWHnZfPq